Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
cx 5461 g quadruplex | 0.97 | 0.9 | 2809 | 100 | 20 |
cx | 1.27 | 0.2 | 4671 | 4 | 2 |
5461 | 1.82 | 0.3 | 4812 | 27 | 4 |
g | 1.04 | 0.3 | 7622 | 72 | 1 |
quadruplex | 1.96 | 0.1 | 3374 | 24 | 10 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
cx-5461 g-quadruplex | 0.74 | 0.3 | 9031 | 94 |
cx 5461 clinical trial | 0.9 | 1 | 3926 | 82 |
cx-5461 | 1.93 | 0.2 | 8004 | 93 |
pidnarulex cx-5461 | 1.23 | 0.7 | 9687 | 64 |
g- quadruplex | 1.54 | 0.9 | 7649 | 17 |
cx-5461 dihydrochloride | 1.15 | 0.7 | 4211 | 80 |
5466.cx | 0.34 | 0.3 | 8123 | 91 |
g-quadruplex cas | 1.33 | 0.2 | 5272 | 90 |
g-quadruplex structure | 1.24 | 0.8 | 62 | 19 |
vx-548 clinical trial | 1.98 | 0.4 | 5498 | 97 |
cl 514 clinical trial | 0.74 | 0.2 | 1691 | 91 |
vx-548 clinical trial phase 3 | 1.86 | 1 | 5593 | 61 |
sndx-5613 clinical trial | 1.5 | 0.2 | 2063 | 2 |
www.clinicaltrials.gov nct05301517 | 0.12 | 0.2 | 5083 | 65 |